Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Ingovax ACWY in Healthy Bangladeshi Adults
NCT03263403Phase 3Completed
- Sponsor
- icddr,b
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ingovax acwy in meningococcal disease, sponsored by icddr,b. Started Aug 2017; status: completed.
02
Drugs
ingovax acwy
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT03263403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263403.